Amy K. Keating

3.6k total citations · 1 hit paper
44 papers, 1.8k citations indexed

About

Amy K. Keating is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Amy K. Keating has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Oncology. Recurrent topics in Amy K. Keating's work include Phagocytosis and Immune Regulation (12 papers), Acute Lymphoblastic Leukemia research (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Amy K. Keating is often cited by papers focused on Phagocytosis and Immune Regulation (12 papers), Acute Lymphoblastic Leukemia research (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Amy K. Keating collaborates with scholars based in United States, Australia and Spain. Amy K. Keating's co-authors include Douglas K. Graham, H. Shelton Earp, Rachel M.A. Linger, Angela Pierce, Xiayuan Liang, Susan Sather, Dana Salzberg, Roger Giller, Kelly K. Sawczyn and Nicholas K. Foreman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Amy K. Keating

43 papers receiving 1.7k citations

Hit Papers

TAM Receptor Tyrosine Kinases: Biologic Functions, Signal... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer
    2008 577 citations Rachel M.A. Linger, Amy K. Keating et al. Advances in cancer research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy K. Keating United States 19 1.1k 399 386 218 203 44 1.8k
Stefano Alivernini Italy 26 851 0.8× 876 2.2× 305 0.8× 333 1.5× 123 0.6× 85 2.6k
Hans P. Kiener Austria 29 700 0.7× 677 1.7× 336 0.9× 209 1.0× 183 0.9× 51 2.2k
Consuelo Blosch United States 8 571 0.5× 509 1.3× 485 1.3× 463 2.1× 156 0.8× 11 2.1k
Andreas Wolf Germany 22 835 0.8× 629 1.6× 1.5k 3.8× 246 1.1× 162 0.8× 40 2.6k
Leigh Samsel United States 26 612 0.6× 568 1.4× 422 1.1× 353 1.6× 78 0.4× 45 1.8k
Gabriel Criado Spain 23 770 0.7× 484 1.2× 287 0.7× 115 0.5× 88 0.4× 48 1.6k
Marjo M. P. C. Donners Netherlands 26 939 0.9× 951 2.4× 293 0.8× 151 0.7× 287 1.4× 51 2.3k
Debra Kukuruga United States 24 344 0.3× 241 0.6× 266 0.7× 198 0.9× 396 2.0× 45 1.4k
Fausto Adami Italy 21 400 0.4× 471 1.2× 355 0.9× 319 1.5× 107 0.5× 50 1.5k
Magdalena Winiarska Poland 20 358 0.3× 432 1.1× 390 1.0× 92 0.4× 100 0.5× 63 1.4k

Countries citing papers authored by Amy K. Keating

Since Specialization
Citations

This map shows the geographic impact of Amy K. Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy K. Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy K. Keating more than expected).

Fields of papers citing papers by Amy K. Keating

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy K. Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy K. Keating. The network helps show where Amy K. Keating may publish in the future.

Co-authorship network of co-authors of Amy K. Keating

This figure shows the co-authorship network connecting the top 25 collaborators of Amy K. Keating. A scholar is included among the top collaborators of Amy K. Keating based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy K. Keating. Amy K. Keating is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
John, Samuel, Kevin J. Curran, Amy K. Keating, et al.. (2025). Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Advances. 9(20). 5249–5262.
2.
3.
4.
Szabolcs, Paul, Roei David Mazor, Dima Yackoubov, et al.. (2023). Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy. Transplantation and Cellular Therapy. 29(8). 517.e1–517.e12. 6 indexed citations
5.
6.
Winestone, Lena E., Erin Sullivan, Qian Wu, et al.. (2023). Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients. Transplantation and Cellular Therapy. 29(6). 356.e1–356.e7. 16 indexed citations
7.
8.
Sopfe, Jenna, Laura Pyle, Amy K. Keating, et al.. (2019). Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients. Blood Advances. 3(3). 350–359. 16 indexed citations
9.
Keating, Amy K., et al.. (2019). Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors. Bone Marrow Transplantation. 54(10). 1605–1613. 4 indexed citations
10.
Sufit, Alexandra, Alisa B. Lee‐Sherick, Deborah DeRyckere, et al.. (2016). MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme. PLoS ONE. 11(10). e0165107–e0165107. 24 indexed citations
11.
Pierce, Angela & Amy K. Keating. (2014). Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors. Journal of Visualized Experiments. 52017–52017. 11 indexed citations
12.
Pierce, Angela & Amy K. Keating. (2013). TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system. Brain Research. 1542. 206–220. 60 indexed citations
13.
Levy, Jean M. Mulcahy, Tiffany Tello, Roger Giller, et al.. (2012). Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age. Pediatric Blood & Cancer. 60(4). 700–704. 52 indexed citations
14.
Rogers, Aaron, et al.. (2011). Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology. Oncogene. 31(38). 4171–4181. 52 indexed citations
15.
Keating, Amy K., Hongbing Jiang, Gary Brodsky, et al.. (2011). Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria. Molecular Genetics and Metabolism. 103(4). 330–337. 24 indexed citations
16.
Keating, Amy K., Andrew M. Donson, Kathryn E. Ware, et al.. (2010). Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity. Molecular Cancer Therapeutics. 9(5). 1298–1307. 120 indexed citations
17.
Alsultan, Abdulrahman, Roger Giller, Dexiang Gao, et al.. (2010). GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome. Bone Marrow Transplantation. 46(5). 668–675. 16 indexed citations
18.
Linger, Rachel M.A., Amy K. Keating, H. Shelton Earp, & Douglas K. Graham. (2008). TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer. Advances in cancer research. 100. 35–83. 577 indexed citations breakdown →
19.
Keating, Amy K., Dana Salzberg, Susan Sather, et al.. (2006). Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene. 25(45). 6092–6100. 76 indexed citations
20.
Keating, Amy K., et al.. (2001). Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.. Blood. 98(11). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Alivernini Breakdown of academic impact, for papers by Hans P. Kiener Breakdown of academic impact, for papers by Consuelo Blosch Breakdown of academic impact, for papers by Andreas Wolf Breakdown of academic impact, for papers by Leigh Samsel Breakdown of academic impact, for papers by Gabriel Criado Breakdown of academic impact, for papers by Marjo M. P. C. Donners Breakdown of academic impact, for papers by Debra Kukuruga Breakdown of academic impact, for papers by Fausto Adami Breakdown of academic impact, for papers by Magdalena Winiarska
Rankless by CCL
2026